Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DDHD1-DT, or "DDHD1 divergent transcript," is a divergent transcript (non-coding RNA) located near the DDHD1 locus. There is no evidence in the major databases, literature, or current gene target resources suggesting that DDHD1-DT encodes a protein, acts as a drug target, or plays an established role in disease. This differentiates it clearly from DDHD1 itself, which encodes an intracellular phospholipase A1 with known involvement in mitochondrial lipid metabolism and hereditary spastic paraplegia. The available references and gene databases (e.g., BioGPS, Ensembl, NCBI) confirm that DDHD1-DT is a non-coding transcript with no protein product or established target function[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DDHD1 divergent transcript (DDHD1-DT).